BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35279700)

  • 21. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
    Alayed K; Patel KP; Konoplev S; Singh RR; Routbort MJ; Reddy N; Pemmaraju N; Zhang L; Shaikh AA; Aladily TN; Jain N; Luthra R; Medeiros LJ; Khoury JD
    Am J Hematol; 2013 Dec; 88(12):1055-61. PubMed ID: 23940084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms.
    Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS
    Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.
    Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD
    Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin.
    Batta K; Bossenbroek HM; Pemmaraju N; Wilks DP; Chasty R; Dennis M; Milne P; Collin M; Beird HC; Taylor J; Patnaik MM; Cargo CA; Somervaille TCP; Wiseman DH
    Leukemia; 2021 Nov; 35(11):3299-3303. PubMed ID: 33833384
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm.
    Nomburg J; Bullman S; Chung SS; Togami K; Walker MA; Griffin GK; Morgan EA; LeBoeuf NR; DeCaprio JA; Meyerson M; Lane AA
    Blood Adv; 2020 Mar; 4(6):1006-1011. PubMed ID: 32182365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastic plasmacytoid dendritic cell neoplasm of the skin associated with myelodysplastic syndrome.
    Kong QT; Zhang M; Sang H; Chen J; Yan W; Hu W; Deng D; Xie Q
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival.
    Shimony S; Keating J; Fay CJ; Luskin MR; Neuberg DS; LeBoeuf NR; Lane AA
    Blood Adv; 2024 Jun; 8(11):2803-2812. PubMed ID: 38603567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [TFH lymphoma and associated clonal hematopoiesis].
    Nann D; Fend F; Quintanilla-Martinez L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
    Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
    Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm].
    Kubota S
    Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report.
    Florescu AM; Sørensen ALT; Nielsen HV; Tolnai D; Sjö LD; Larsen KL; Al-Karagholi MA
    BMC Neurol; 2022 Jun; 22(1):233. PubMed ID: 35751052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report.
    Luo F; Li B; Li J; Li Y
    Oncol Lett; 2024 May; 27(5):220. PubMed ID: 38586204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023.
    Pemmaraju N; Kantarjian H
    Clin Adv Hematol Oncol; 2023 May; 21(5):257-264. PubMed ID: 37145496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
    Sapienza MR; Pileri S
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
    Wang S; Wang X; Liu M; Bai O
    Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis.
    Renosi F; Roggy A; Giguelay A; Soret L; Viailly PJ; Cheok M; Biichle S; Angelot-Delettre F; Asnafi V; Macintyre E; Geffroy S; Callanan M; Petrella T; Deconinck E; Daguindau E; Harrivel V; Bouyer S; Salaun V; Saussoy P; Feuillard J; Fuseau P; Saas P; Adotévi O; Jardin F; Ferrand C; Preudhomme C; Colinge J; Roumier C; Garnache-Ottou F
    Blood Adv; 2021 Mar; 5(5):1540-1551. PubMed ID: 33687433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
    Tzankov A; Hebeda K; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U
    Ann Hematol; 2017 May; 96(5):765-777. PubMed ID: 28191591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases.
    Ohgami RS; Aung PP; Gru AA; Hussaini M; Singh K; Querfeld C; Yao K; Small C; Gollapudi S; Jaye D; Wang SA; Pullarkat S; George TI
    Arch Pathol Lab Med; 2023 Jul; 147(7):837-846. PubMed ID: 36170615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.